Latest filingSep 02, 2026Most recent Form 4
CAMP
Camp4 Therapeutics Corp
NasdaqHealthcarePharmaceutical Preparations
Insider activity for last month from 08/03 to 09/03. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$3.96M1 buys
Total selling$250M6 sells
Net open-market-$246M3 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period7transactions
- S · Open-market sells · dominant6 · 86%
- P · Open-market buys1 · 14%
Activity by reported role
A joint filing can contribute to multiple roles7transactions
- Director · dominant5 · 71%
- Chief financial officer1 · 14%
- CSO1 · 14%
Distinct insiders active
Reporting-owner CIKs by month · peak Aug 2026 (3)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeSchwab Andrew J.Common Stock · Indirect · By 5AM Ventures VI, L.P.
2,033,270Aug 27, 2026
Tardiff DanielCommon Stock · Direct
0Aug 19, 2026
Gold KellyCommon Stock · Indirect · By Spouse
10,000Aug 31, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 03 → Sep 03
LessMore
Top insiders
By absolute net value across the selected period- GK+$39.6k
Recent filing activity
Most recent 1 transactions · color = transaction code- PBuy09/02$3.96MSEC
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
CAMP transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| CAMP | Gold Kelly | CFO | buy | 10.0k | $3.96M | P | — | 0.0% | 09/02 | 08/31 |
Camp4 Therapeutics Corp Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Camp4 Therapeutics Corp?
Gold Kelly, Schwab Andrew J., Tardiff Daniel.
When was the latest reported open-market purchase?
Gold Kelly reported a buy on Aug 31, 2026 valued at $3.96M. Read the SEC filing.
When was the latest reported open-market sale?
Schwab Andrew J. reported a sale on Aug 27, 2026 valued at $161M. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $2,464,436.60. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.